SlideShare a Scribd company logo
1 of 34
Download to read offline
Pharmacophore Mapping in Drug 
Development 
MBACHU Chinedu C. 
Matric No: 172725 
(Direct Reading Seminar) 
Department of Pharmaceutical Chemistry 
Faculty of Pharmacy 
University of Ibadan
Definitions of Pharmacophore 
Features 
Rational drug design 
Virtual Screening 
Classification of Pharmacophore Drug 
Design 
Docking Process 
Applications of Pharmacophore Models 
Case Study 
Conclusion 
References 
Acknowledgement 
2
Definitions and features 
Features 
• Hydrophobic centroids 
•Aromatic rings 
• Hydrogen bond 
acceptors HBA or 
• Hydrogen bond donor 
HBD 
•Cation and 
•Anions 
3 
 A pharmacophore is an abstract 
description of molecular features which 
are necessary for molecular recognition of 
a ligand by a biological macromolecule. 
 A pharmacophore is a representation of 
generalized molecular features including; 
3D (hydrophobic groups, 
charged/ionizable groups, hydrogen bond 
donors/acceptors), 2D (substructures), 
and 1D (physical or biological) properties 
that are considered to be responsible for 
a desired biological activity 
 Pharmacophore Mapping is the 
definition and placement of 
pharmacophoric features and the 
alignment techniques used to overlay 3D
Simply 
4 
• Two somewhat distinct usages: 
• That substructure of a molecule that is responsible for its pharmacological 
activity (c.f. chromophore) 
• A set of geometrical constraints between specific functional groups that 
enable the molecule to have biological activity 
Bojarski, Curr. Top. Med. Chem. 2006, 6, 
2005.
Rational Drug Design 
5 
 Use knowledge of protein or ligand structures 
 Does not rely on trial-and-error or screening 
 Computer-aided drug design (CADD) now plays an important role in 
rational design 
 Structure-based drug design 
 Uses protein structure directly 
 CADD: Protein-ligand docking 
 Ligand-based drug design 
 Derive information from ligand structures 
 Protein structure not always available 
 40% of all prescription pharmaceuticals target GPCRs 
 Protein structure has large degree of flexibility 
 Structure deforms to accommodate ligands or gross movements occur 
on binding 
 CADD: Pharmacophore approach, Quantitative structure-activity 
relationship (QSAR)
Drug Design 
 The process of finding drug by design. 
 Based on what the drug targeting? 
 Metabolic or Signaling pathway 
6 
Specific for disease or pathology. 
Drugs 
Bind to active site & Work. 
“A substances used in 
the diagnosis, 
treatment or 
prevention of disease.
Overview of Pharmacophore-based Drug Design 
7 
Activity data 
Generate 
pharmacophore 
Search compound 
library for actives 
Test activity 
Buy or synthesise ‘hits’ 
pharmacophore.org
Virtual Screening 
 Computational technique. 
 Producing large libraries of compound that docked in 
to the binding site using computer programme. 
 The goal is finding interesting new scaffolds rather 
than many hits. 
 Low hits rate are clearly very preferable.
Virtual screening 
 Virtual screening is the computational or in silico 
analogue of biological screening 
 The aim is to score, rank or filter a set of structures 
using one or more computational procedures 
 It can be used 
 to help decide which compounds to screen (experimentally) 
 which libraries to synthesise 
 which compounds to purchase from an external company 
 to analyse the results of an experiment, such as a HTS run
Virtual screening 
AR Leach, VJ Gillet, An Introduction to Cheminformatics
OUR TARGET 
11
classification 
12
13 
Docking process 
Descriptions of the 
receptor 3D structure, 
binding site and ligand 
Sampling of the 
configuration space of the 
binding complex 
Evaluating free energy of 
binding for scoring 
Local/global minimum 
Ensemble of 
protein structures 
and/or mutiple 
ligands 
Multiple binding 
configurations for a 
single protein 
structcture and a 
ligand
Protein-ligand docking 
14 
 A Structure-Based Drug Design (SBDD) method 
 “structure” means “using protein structure” 
 Computational method that mimics the binding of a ligand to a 
protein 
 Given... 
• Predicts... 
• The pose of the molecule in 
the binding site 
• The binding affinity or a 
score representing the 
strength of binding 
Image credit: Charaka Goonatilake, Glen Group, University of Cambridge. http://www-ucc. 
ch.cam.ac.uk/research/cg369-research.html
Flexibility in docking 
 Systematic search 
 Monte Carlo methods (MC) 
 Molecular Dynamics (MD) 
 Simulated Annealing (SA) 
 Genetic Algorithms (GA) 
15 
Available in packages: 
AutoDock (MC,GA,SA) 
GOLD (GA) 
Sybyl (MD) 
Docking programs 
DOCK 
FlexX 
GOLD 
AutoDOCK 
Hammerhead 
FLOG
The perfect scoring function will… 
16 
 Accurately calculate the binding affinity 
 Will allow actives to be identified in a virtual screen 
 Be able to rank actives in terms of affinity 
 Score the poses of an active higher than poses of an 
inactive 
 Will rank actives higher than inactives in a virtual screen 
 Score the correct pose of the active higher than an 
incorrect pose of the active 
 Will allow the correct pose of the active to be identified 
 Broadly speaking, scoring functions can be divided into the 
following classes: 
 Forcefield-based 
 Based on terms from molecular mechanics forcefields 
 GoldScore, DOCK, AutoDock 
 Empirical 
 Parameterised against experimental binding affinities 
 ChemScore, PLP, Glide SP/XP 
 Knowledge-based potentials 
 Based on statistical analysis of observed pairwise distributions 
 PMF, DrugScore, ASP
17
APPLICATIONS 
18
CASE STUDY 
Virtual Lead Identification of Farnesyltransferase 
Inhibitors Based on Ligand and Structure-Based 
Pharmacophore Techniques 
 Ftase is an essential enzyme in the Ras signaling 
pathway associated with cancer 
 Thus, designing inhibitors for this enzyme might 
lead to the discovery of compounds with effective 
anticancer activity 
pharmacophore hypotheses were generated using 
structure-based and ligand-based approaches built 
in Discovery Studio v3.1. 
Knowing the presence of the zinc feature is 
essential for inhibitor’s binding to the active site of 
19 
FTase enzyme
 further customization was applied to include this 
feature in the generated pharmacophore hypotheses 
Thorough validation using ROC analysis and ligand 
pharmacophore mapping 
 The hypotheses were used to screen 3D databases 
to identify possible hits 
high ranked hits that showed sufficient ability to bind 
the zinc feature in active site, were further refined by 
applying drug-like criteria (Lipiniski’s “rule of five” and 
ADMET filters) 
Finally, the two candidate compounds 
ZINC39323901 and ZINC01034774 were allowed to 
dock using CDOCKER and GOLD in the active site 
20 
of FTase enzyme to optimize hit selection
2D structures 
21
Features pharmacophore 
22 
Ranked 
Higher
Fitness 
23 
Best Inhibitor
Mapping of Pharm-3A with 2ZIS-NH8903 
24
Structure-Based hypothesis 
25
Mapping of Pharm-3A over Pharm-B 
26
Structure-based fitness 
27 
Same with Pharm-3A
Mapping of 2ZIS-NH8903 on Pharm- 
3B 
28
Steps in Graphics 
29
Conclusion 
 The pharmacophore concept is a successful 
and well-known approach for drug design (both 
ligand and structure based) as well as for 
virtual screening 
 Pharmacophoric mapping is a promising 
concept in the development of drug within 
shorter time and limited resources when 
compared with the conventional drug 
development process 
30
References 
Elumalai P, Liu HL, Zhao JH. et al. Pharmacophore modeling, virtual screening and 
31 
docking studies to identify novel HNMT inhibitors. J TAIWAN INST CHEM. 2012 
doi:10.1016/j.jtice.2012.01.004. 
Gu¨ner, O.F. 2000 Pharmacophore Perception Development and Use in Drug Design, 
International University Line Langer, T. and Hoffmann, R.D. 2006 Pharmacophores and 
Pharmacophore Searches,Wiley VCH. 
Kirchmair, J. et al. (2005) Comparative analysis of protein-bound ligand conformations with 
respect to catalyst’s conformational space sub- sampling algorithms. J. Chem. Inf. Model. 
45, 422–430. 
Kirchmair, J. et al. 2006 Comparative performance assessment of the conformational model 
generators Omega and Catalyst: a large scale survey on the retrieval of protein-bound 
ligand conformations. J. Chem. Inf. Model. 46,422–430. 
Kubinyi, H. 2006 Success stories of computer-aided design. In ComputerApplications in 
Pharmaceutical Research and Development(Ekins,S.,ed.),pp.377–424, Wiley- 
Interscience, New York.
References 
Lindsley CW, Zhao Z, Leister WH. et al. Allosteric Akt (PKB) inhibitors: discovery and 
32 
SAR of isozyme selective inhibitors. BIOORG MED CHEM LETT. 2005;15:761-764 
Patel, Y. et al. 2002 A comparison of the pharmacophore identification programs: catalyst, 
DISCO and GASP. J. Comput. Aid. Mol. Des. 16, 653 681. 
Qosay A. A., Haneen A. A. et al,; Virtual Lead Identification of Farnesyltransferase 
Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques; 
Pharmaceuticals 27 May 2013 6, 700-715; doi:10.3390/ph6060700 
Wermuth,C.G.andLanger,T.1993 Pharmacophore identification In 3D-QSAR in Drug 
Design. Theory, Methods and Applications (Kubinyi, H., ed.), pp. 117136, ESCOM. 
Wolber, G. and Langer, T. 2005 LigandScout: 3D pharmacophores derived from protein 
boundlig and sand their use as virtual screening filters. J.Chem. Inf. Model. 45, 160– 
169. 
Wolber, G. and Dornhofer, A. A.2006 Efficient over lay of small organic molecules using 
3D pharmacophores. J. Comput. Aid. Mol. Des.20, 773–788. 
Wolber, G. and Kosara, R. 2006 Pharmacophores from macromolecular complexes with 
Ligand Scout. In Pharmacophores and Pharmacophore Searches,(vol.32) (Langer, T. 
and Hoffmann, R.D., eds) pp. 131–150, Wiley-VCH.
Acknowledgement 
Dr B.B. Samuel 
33
34 
THANK YOU 
FOR LISTENING

More Related Content

What's hot

CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)Pinky Vincent
 
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTPHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTShikha Popali
 
In Silico methods for ADMET prediction of new molecules
 In Silico methods for ADMET prediction of new molecules In Silico methods for ADMET prediction of new molecules
In Silico methods for ADMET prediction of new moleculesMadhuraDatar
 
STATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARSTATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARRaniBhagat1
 
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDQSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDGagangowda58
 
QSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureQSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureSaramita De Chakravarti
 
Virtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryVirtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryAbhik Seal
 
Molecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniquesMolecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniquesTheabhi.in
 
Virtual screening techniques
Virtual screening techniquesVirtual screening techniques
Virtual screening techniquesROHIT PAL
 
Structure based in silico virtual screening
Structure based in silico virtual screeningStructure based in silico virtual screening
Structure based in silico virtual screeningJoon Jyoti Sahariah
 
Virtual screening ppt
Virtual screening pptVirtual screening ppt
Virtual screening pptVivekYadav490
 
2D VS 3D QSAR.pptx
2D VS 3D QSAR.pptx2D VS 3D QSAR.pptx
2D VS 3D QSAR.pptxArnabPanja4
 
Molecular maodeling and drug design
Molecular maodeling and drug designMolecular maodeling and drug design
Molecular maodeling and drug designMahendra G S
 

What's hot (20)

CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)
 
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTPHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENT
 
3d qsar
3d qsar3d qsar
3d qsar
 
In Silico methods for ADMET prediction of new molecules
 In Silico methods for ADMET prediction of new molecules In Silico methods for ADMET prediction of new molecules
In Silico methods for ADMET prediction of new molecules
 
STATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARSTATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSAR
 
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDQSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
 
QSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureQSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative Structure
 
Virtual Screening in Drug Discovery
Virtual Screening in Drug DiscoveryVirtual Screening in Drug Discovery
Virtual Screening in Drug Discovery
 
2D - QSAR
2D - QSAR2D - QSAR
2D - QSAR
 
Molecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniquesMolecular Modeling and virtual screening techniques
Molecular Modeling and virtual screening techniques
 
Virtual screening techniques
Virtual screening techniquesVirtual screening techniques
Virtual screening techniques
 
Pharmacophore
PharmacophorePharmacophore
Pharmacophore
 
Structure based in silico virtual screening
Structure based in silico virtual screeningStructure based in silico virtual screening
Structure based in silico virtual screening
 
Virtual screening ppt
Virtual screening pptVirtual screening ppt
Virtual screening ppt
 
Virtual sreening
Virtual sreeningVirtual sreening
Virtual sreening
 
Pharmacophore identification
Pharmacophore identificationPharmacophore identification
Pharmacophore identification
 
2D VS 3D QSAR.pptx
2D VS 3D QSAR.pptx2D VS 3D QSAR.pptx
2D VS 3D QSAR.pptx
 
QSAR by Faizan Deshmukh
QSAR by Faizan DeshmukhQSAR by Faizan Deshmukh
QSAR by Faizan Deshmukh
 
Molecular maodeling and drug design
Molecular maodeling and drug designMolecular maodeling and drug design
Molecular maodeling and drug design
 
MOLECULAR DOCKING
MOLECULAR DOCKINGMOLECULAR DOCKING
MOLECULAR DOCKING
 

Viewers also liked

Pharmacophore mapping
Pharmacophore mappingPharmacophore mapping
Pharmacophore mapping12nima34
 
Pharmacophore Modeling in Drug Designing
Pharmacophore Modeling in Drug DesigningPharmacophore Modeling in Drug Designing
Pharmacophore Modeling in Drug DesigningVinod Tonde
 
Pharmacohoreppt
PharmacohorepptPharmacohoreppt
PharmacohorepptAbhik Seal
 
Pharmacophore
PharmacophorePharmacophore
Pharmacophoreirecen
 
Qsar and drug design ppt
Qsar and drug design pptQsar and drug design ppt
Qsar and drug design pptAbhik Seal
 
Structure based drug design
Structure based drug designStructure based drug design
Structure based drug designADAM S
 
consensus superiority of the pharmacophore based alignment, over maximum comm...
consensus superiority of the pharmacophore based alignment, over maximum comm...consensus superiority of the pharmacophore based alignment, over maximum comm...
consensus superiority of the pharmacophore based alignment, over maximum comm...Deepak Rohilla
 
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...Prasanthperceptron
 
Computer aided drug designing
Computer aided drug designingComputer aided drug designing
Computer aided drug designingMuhammed sadiq
 
Computer aided drug designing
Computer aided drug designing Computer aided drug designing
Computer aided drug designing Ayesha Aftab
 
Rational drug design
Rational drug designRational drug design
Rational drug designNaresh Juttu
 
Molecular docking
Molecular dockingMolecular docking
Molecular dockingRahul B S
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and developmentrahul_pharma
 
Thesis defense - QUANG ONG - FINAL
Thesis defense - QUANG ONG - FINALThesis defense - QUANG ONG - FINAL
Thesis defense - QUANG ONG - FINALQuang Ong
 
USUGM 2014 - Gerald Wyckoff (Chemalytics): Development of the Chemalytics Pl...
USUGM 2014 -  Gerald Wyckoff (Chemalytics): Development of the Chemalytics Pl...USUGM 2014 -  Gerald Wyckoff (Chemalytics): Development of the Chemalytics Pl...
USUGM 2014 - Gerald Wyckoff (Chemalytics): Development of the Chemalytics Pl...ChemAxon
 
Presentation rise student 2
Presentation rise student 2Presentation rise student 2
Presentation rise student 2angelinfigueroa
 

Viewers also liked (20)

Pharmacophore mapping
Pharmacophore mappingPharmacophore mapping
Pharmacophore mapping
 
Pharmacophore Modeling in Drug Designing
Pharmacophore Modeling in Drug DesigningPharmacophore Modeling in Drug Designing
Pharmacophore Modeling in Drug Designing
 
Pharmacohoreppt
PharmacohorepptPharmacohoreppt
Pharmacohoreppt
 
Pharmacophore
PharmacophorePharmacophore
Pharmacophore
 
Qsar and drug design ppt
Qsar and drug design pptQsar and drug design ppt
Qsar and drug design ppt
 
Structure based drug design
Structure based drug designStructure based drug design
Structure based drug design
 
consensus superiority of the pharmacophore based alignment, over maximum comm...
consensus superiority of the pharmacophore based alignment, over maximum comm...consensus superiority of the pharmacophore based alignment, over maximum comm...
consensus superiority of the pharmacophore based alignment, over maximum comm...
 
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...
 
Denovo Drug Design
Denovo Drug DesignDenovo Drug Design
Denovo Drug Design
 
Computer aided drug designing
Computer aided drug designingComputer aided drug designing
Computer aided drug designing
 
Qsar by hansch analysis
Qsar by hansch analysisQsar by hansch analysis
Qsar by hansch analysis
 
Computer aided drug designing
Computer aided drug designing Computer aided drug designing
Computer aided drug designing
 
Rational drug design
Rational drug designRational drug design
Rational drug design
 
Computer Aided Drug Design ppt
Computer Aided Drug Design pptComputer Aided Drug Design ppt
Computer Aided Drug Design ppt
 
Molecular docking
Molecular dockingMolecular docking
Molecular docking
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 
Novelty on patents
Novelty on patentsNovelty on patents
Novelty on patents
 
Thesis defense - QUANG ONG - FINAL
Thesis defense - QUANG ONG - FINALThesis defense - QUANG ONG - FINAL
Thesis defense - QUANG ONG - FINAL
 
USUGM 2014 - Gerald Wyckoff (Chemalytics): Development of the Chemalytics Pl...
USUGM 2014 -  Gerald Wyckoff (Chemalytics): Development of the Chemalytics Pl...USUGM 2014 -  Gerald Wyckoff (Chemalytics): Development of the Chemalytics Pl...
USUGM 2014 - Gerald Wyckoff (Chemalytics): Development of the Chemalytics Pl...
 
Presentation rise student 2
Presentation rise student 2Presentation rise student 2
Presentation rise student 2
 

Similar to Pharmacophore mapping in Drug Development

pharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxpharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxashharnomani
 
Significance of computational tools in drug discovery
Significance of computational tools in drug discoverySignificance of computational tools in drug discovery
Significance of computational tools in drug discoveryDrMopuriDeepaReddy
 
Pharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screeningPharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screeningSanchit Dhankhar
 
Cadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.PharmCadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.PharmShikha Popali
 
presentation on in silico studies
presentation on in silico studiespresentation on in silico studies
presentation on in silico studiesShaik Sana
 
“Docking Studies and Drug Design”
“Docking  Studies and Drug Design”“Docking  Studies and Drug Design”
“Docking Studies and Drug Design”Naresh Juttu
 
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...Trustlife
 
Lecture 4 ligand based drug design
Lecture 4 ligand based drug designLecture 4 ligand based drug design
Lecture 4 ligand based drug designRAJAN ROLTA
 
various approaches in drug design and molecular docking.pptx
various approaches in drug design and molecular docking.pptxvarious approaches in drug design and molecular docking.pptx
various approaches in drug design and molecular docking.pptxpranalpatilPranal
 
Virtual screening strategies and applications
Virtual screening strategies and applicationsVirtual screening strategies and applications
Virtual screening strategies and applicationsAshishkumar3249
 
Computer aided drug design(CADD)
Computer aided drug design(CADD)Computer aided drug design(CADD)
Computer aided drug design(CADD)Sameh Abdel-ghany
 
Caddfinal 170310151334
Caddfinal 170310151334Caddfinal 170310151334
Caddfinal 170310151334TimurKharsiev
 
Determining stable ligand orientation
Determining stable ligand orientationDetermining stable ligand orientation
Determining stable ligand orientationijaia
 

Similar to Pharmacophore mapping in Drug Development (20)

pharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxpharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptx
 
Significance of computational tools in drug discovery
Significance of computational tools in drug discoverySignificance of computational tools in drug discovery
Significance of computational tools in drug discovery
 
Virtual screening
Virtual screeningVirtual screening
Virtual screening
 
Cadd
CaddCadd
Cadd
 
Pharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screeningPharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screening
 
Computer Aided Drug Design
Computer Aided Drug DesignComputer Aided Drug Design
Computer Aided Drug Design
 
Cadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.PharmCadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.Pharm
 
presentation on in silico studies
presentation on in silico studiespresentation on in silico studies
presentation on in silico studies
 
“Docking Studies and Drug Design”
“Docking  Studies and Drug Design”“Docking  Studies and Drug Design”
“Docking Studies and Drug Design”
 
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
BioExpo 2023 Presentation - Computational Chemistry in Drug Discovery: Bridgi...
 
Ligand based drug desighning
Ligand based drug desighningLigand based drug desighning
Ligand based drug desighning
 
Lecture 4 ligand based drug design
Lecture 4 ligand based drug designLecture 4 ligand based drug design
Lecture 4 ligand based drug design
 
Qsar ppt
Qsar pptQsar ppt
Qsar ppt
 
various approaches in drug design and molecular docking.pptx
various approaches in drug design and molecular docking.pptxvarious approaches in drug design and molecular docking.pptx
various approaches in drug design and molecular docking.pptx
 
cadd .pptx
cadd .pptxcadd .pptx
cadd .pptx
 
Drug design
Drug designDrug design
Drug design
 
Virtual screening strategies and applications
Virtual screening strategies and applicationsVirtual screening strategies and applications
Virtual screening strategies and applications
 
Computer aided drug design(CADD)
Computer aided drug design(CADD)Computer aided drug design(CADD)
Computer aided drug design(CADD)
 
Caddfinal 170310151334
Caddfinal 170310151334Caddfinal 170310151334
Caddfinal 170310151334
 
Determining stable ligand orientation
Determining stable ligand orientationDetermining stable ligand orientation
Determining stable ligand orientation
 

Recently uploaded

How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesCeline George
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxMYDA ANGELICA SUAN
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsEugene Lysak
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxEduSkills OECD
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesMohammad Hassany
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and stepobaje godwin sunday
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17Celine George
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17Celine George
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfTechSoup
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17Celine George
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICESayali Powar
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxDr. Asif Anas
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptxSandy Millin
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17Celine George
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 

Recently uploaded (20)

How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 Sales
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
Patterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptxPatterns of Written Texts Across Disciplines.pptx
Patterns of Written Texts Across Disciplines.pptx
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George Wells
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming Classes
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and step
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17
 
Quality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICEQuality Assurance_GOOD LABORATORY PRACTICE
Quality Assurance_GOOD LABORATORY PRACTICE
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptx
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 

Pharmacophore mapping in Drug Development

  • 1. Pharmacophore Mapping in Drug Development MBACHU Chinedu C. Matric No: 172725 (Direct Reading Seminar) Department of Pharmaceutical Chemistry Faculty of Pharmacy University of Ibadan
  • 2. Definitions of Pharmacophore Features Rational drug design Virtual Screening Classification of Pharmacophore Drug Design Docking Process Applications of Pharmacophore Models Case Study Conclusion References Acknowledgement 2
  • 3. Definitions and features Features • Hydrophobic centroids •Aromatic rings • Hydrogen bond acceptors HBA or • Hydrogen bond donor HBD •Cation and •Anions 3  A pharmacophore is an abstract description of molecular features which are necessary for molecular recognition of a ligand by a biological macromolecule.  A pharmacophore is a representation of generalized molecular features including; 3D (hydrophobic groups, charged/ionizable groups, hydrogen bond donors/acceptors), 2D (substructures), and 1D (physical or biological) properties that are considered to be responsible for a desired biological activity  Pharmacophore Mapping is the definition and placement of pharmacophoric features and the alignment techniques used to overlay 3D
  • 4. Simply 4 • Two somewhat distinct usages: • That substructure of a molecule that is responsible for its pharmacological activity (c.f. chromophore) • A set of geometrical constraints between specific functional groups that enable the molecule to have biological activity Bojarski, Curr. Top. Med. Chem. 2006, 6, 2005.
  • 5. Rational Drug Design 5  Use knowledge of protein or ligand structures  Does not rely on trial-and-error or screening  Computer-aided drug design (CADD) now plays an important role in rational design  Structure-based drug design  Uses protein structure directly  CADD: Protein-ligand docking  Ligand-based drug design  Derive information from ligand structures  Protein structure not always available  40% of all prescription pharmaceuticals target GPCRs  Protein structure has large degree of flexibility  Structure deforms to accommodate ligands or gross movements occur on binding  CADD: Pharmacophore approach, Quantitative structure-activity relationship (QSAR)
  • 6. Drug Design  The process of finding drug by design.  Based on what the drug targeting?  Metabolic or Signaling pathway 6 Specific for disease or pathology. Drugs Bind to active site & Work. “A substances used in the diagnosis, treatment or prevention of disease.
  • 7. Overview of Pharmacophore-based Drug Design 7 Activity data Generate pharmacophore Search compound library for actives Test activity Buy or synthesise ‘hits’ pharmacophore.org
  • 8. Virtual Screening  Computational technique.  Producing large libraries of compound that docked in to the binding site using computer programme.  The goal is finding interesting new scaffolds rather than many hits.  Low hits rate are clearly very preferable.
  • 9. Virtual screening  Virtual screening is the computational or in silico analogue of biological screening  The aim is to score, rank or filter a set of structures using one or more computational procedures  It can be used  to help decide which compounds to screen (experimentally)  which libraries to synthesise  which compounds to purchase from an external company  to analyse the results of an experiment, such as a HTS run
  • 10. Virtual screening AR Leach, VJ Gillet, An Introduction to Cheminformatics
  • 13. 13 Docking process Descriptions of the receptor 3D structure, binding site and ligand Sampling of the configuration space of the binding complex Evaluating free energy of binding for scoring Local/global minimum Ensemble of protein structures and/or mutiple ligands Multiple binding configurations for a single protein structcture and a ligand
  • 14. Protein-ligand docking 14  A Structure-Based Drug Design (SBDD) method  “structure” means “using protein structure”  Computational method that mimics the binding of a ligand to a protein  Given... • Predicts... • The pose of the molecule in the binding site • The binding affinity or a score representing the strength of binding Image credit: Charaka Goonatilake, Glen Group, University of Cambridge. http://www-ucc. ch.cam.ac.uk/research/cg369-research.html
  • 15. Flexibility in docking  Systematic search  Monte Carlo methods (MC)  Molecular Dynamics (MD)  Simulated Annealing (SA)  Genetic Algorithms (GA) 15 Available in packages: AutoDock (MC,GA,SA) GOLD (GA) Sybyl (MD) Docking programs DOCK FlexX GOLD AutoDOCK Hammerhead FLOG
  • 16. The perfect scoring function will… 16  Accurately calculate the binding affinity  Will allow actives to be identified in a virtual screen  Be able to rank actives in terms of affinity  Score the poses of an active higher than poses of an inactive  Will rank actives higher than inactives in a virtual screen  Score the correct pose of the active higher than an incorrect pose of the active  Will allow the correct pose of the active to be identified  Broadly speaking, scoring functions can be divided into the following classes:  Forcefield-based  Based on terms from molecular mechanics forcefields  GoldScore, DOCK, AutoDock  Empirical  Parameterised against experimental binding affinities  ChemScore, PLP, Glide SP/XP  Knowledge-based potentials  Based on statistical analysis of observed pairwise distributions  PMF, DrugScore, ASP
  • 17. 17
  • 19. CASE STUDY Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques  Ftase is an essential enzyme in the Ras signaling pathway associated with cancer  Thus, designing inhibitors for this enzyme might lead to the discovery of compounds with effective anticancer activity pharmacophore hypotheses were generated using structure-based and ligand-based approaches built in Discovery Studio v3.1. Knowing the presence of the zinc feature is essential for inhibitor’s binding to the active site of 19 FTase enzyme
  • 20.  further customization was applied to include this feature in the generated pharmacophore hypotheses Thorough validation using ROC analysis and ligand pharmacophore mapping  The hypotheses were used to screen 3D databases to identify possible hits high ranked hits that showed sufficient ability to bind the zinc feature in active site, were further refined by applying drug-like criteria (Lipiniski’s “rule of five” and ADMET filters) Finally, the two candidate compounds ZINC39323901 and ZINC01034774 were allowed to dock using CDOCKER and GOLD in the active site 20 of FTase enzyme to optimize hit selection
  • 22. Features pharmacophore 22 Ranked Higher
  • 23. Fitness 23 Best Inhibitor
  • 24. Mapping of Pharm-3A with 2ZIS-NH8903 24
  • 26. Mapping of Pharm-3A over Pharm-B 26
  • 27. Structure-based fitness 27 Same with Pharm-3A
  • 28. Mapping of 2ZIS-NH8903 on Pharm- 3B 28
  • 30. Conclusion  The pharmacophore concept is a successful and well-known approach for drug design (both ligand and structure based) as well as for virtual screening  Pharmacophoric mapping is a promising concept in the development of drug within shorter time and limited resources when compared with the conventional drug development process 30
  • 31. References Elumalai P, Liu HL, Zhao JH. et al. Pharmacophore modeling, virtual screening and 31 docking studies to identify novel HNMT inhibitors. J TAIWAN INST CHEM. 2012 doi:10.1016/j.jtice.2012.01.004. Gu¨ner, O.F. 2000 Pharmacophore Perception Development and Use in Drug Design, International University Line Langer, T. and Hoffmann, R.D. 2006 Pharmacophores and Pharmacophore Searches,Wiley VCH. Kirchmair, J. et al. (2005) Comparative analysis of protein-bound ligand conformations with respect to catalyst’s conformational space sub- sampling algorithms. J. Chem. Inf. Model. 45, 422–430. Kirchmair, J. et al. 2006 Comparative performance assessment of the conformational model generators Omega and Catalyst: a large scale survey on the retrieval of protein-bound ligand conformations. J. Chem. Inf. Model. 46,422–430. Kubinyi, H. 2006 Success stories of computer-aided design. In ComputerApplications in Pharmaceutical Research and Development(Ekins,S.,ed.),pp.377–424, Wiley- Interscience, New York.
  • 32. References Lindsley CW, Zhao Z, Leister WH. et al. Allosteric Akt (PKB) inhibitors: discovery and 32 SAR of isozyme selective inhibitors. BIOORG MED CHEM LETT. 2005;15:761-764 Patel, Y. et al. 2002 A comparison of the pharmacophore identification programs: catalyst, DISCO and GASP. J. Comput. Aid. Mol. Des. 16, 653 681. Qosay A. A., Haneen A. A. et al,; Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques; Pharmaceuticals 27 May 2013 6, 700-715; doi:10.3390/ph6060700 Wermuth,C.G.andLanger,T.1993 Pharmacophore identification In 3D-QSAR in Drug Design. Theory, Methods and Applications (Kubinyi, H., ed.), pp. 117136, ESCOM. Wolber, G. and Langer, T. 2005 LigandScout: 3D pharmacophores derived from protein boundlig and sand their use as virtual screening filters. J.Chem. Inf. Model. 45, 160– 169. Wolber, G. and Dornhofer, A. A.2006 Efficient over lay of small organic molecules using 3D pharmacophores. J. Comput. Aid. Mol. Des.20, 773–788. Wolber, G. and Kosara, R. 2006 Pharmacophores from macromolecular complexes with Ligand Scout. In Pharmacophores and Pharmacophore Searches,(vol.32) (Langer, T. and Hoffmann, R.D., eds) pp. 131–150, Wiley-VCH.
  • 34. 34 THANK YOU FOR LISTENING